Rising atherosclerotic cardiovascular disease-related mortality among older adults in the United States: A 22-year retrospective cohort study using the CDC WONDER database
- PMID: 40701437
- DOI: 10.1016/j.hjc.2025.06.001
Rising atherosclerotic cardiovascular disease-related mortality among older adults in the United States: A 22-year retrospective cohort study using the CDC WONDER database
Abstract
Background: Atherosclerotic cardiovascular disease (ASCVD) significantly contributes to morbidity and mortality in the United States. However, data on ASCVD-related mortality trends among older adults remain limited. This study aims to delineate contemporary mortality trends across various sociodemographic and regional groups in the United States.
Methods: We queried the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) for ASCVD-related death data from 1999 to 2021, focusing on demographic factors (sex, race/ethnicity) and geographic regions (state, urban-rural). We calculated age-adjusted mortality rates (AAMRs) per 100,000 individuals and determined annual percentage changes (APCs) using the Joinpoint Regression Program Version 5.2.0.0.
Results: From 1999 to 2021, there were 9,307,495 ASCVD-related deaths among older adults. The AAMR declined sharply from 1,370.7 per 100,000 in 1999 to 803.5 in 2014, with an APC of -3.63%. This decline was followed by a stable period from 2014 to 2019, after which the AAMR rose from 741.3 in 2019 to 841.5 in 2021, yielding an APC of 6.99%. Overall, males exhibited a higher average AAMR (1,269.2) than females (749.8). Among racial groups, non-Hispanic (NH) White individuals had the highest AAMR (988.3), whereas NH Asian and Pacific Islander individuals had the lowest (536.7). Geographically, the Northeast showed the highest AAMR (1067.8) compared with the western region (899.2). Rural areas also displayed a significantly higher AAMR (993.5) than urban areas (954.7).
Conclusion: Despite initial improvements in ASCVD-related mortality, recent trends indicate an increase. Notable disparities persist across demographic and regional groups, underscoring the need for further investigation.
Keywords: ASCVD; Atherosclerotic cardiovascular disease; CDC WONDER; Disparities; Mortality; Trends; United States.
Copyright © 2025 Hellenic Society of Cardiology. Publishing services by Elsevier Inc. All rights reserved.
Similar articles
-
Hypertension and sleep apnea as contributor to mortality trends in the United States: CDC WONDER data analysis.Sleep Med. 2025 Aug 21;135:106742. doi: 10.1016/j.sleep.2025.106742. Online ahead of print. Sleep Med. 2025. PMID: 40848533
-
Trends in United States mortality among patients with atrial fibrillation/flutter related heart failure (1999-2024): disparities by gender, race/ethnicity and region.BMC Cardiovasc Disord. 2025 Jul 31;25(1):558. doi: 10.1186/s12872-025-05036-5. BMC Cardiovasc Disord. 2025. PMID: 40739190 Free PMC article.
-
Mortality trends of renal diseases due to hypertension in adults: an analysis of gender, race, place of death, and geographical disparities in the United States from 1999 to 2020.Int Urol Nephrol. 2025 Sep;57(9):2995-3008. doi: 10.1007/s11255-025-04493-3. Epub 2025 Apr 4. Int Urol Nephrol. 2025. PMID: 40183882
-
Ischemic heart disease-related mortality trends in the United States (1999-2020) and prediction using machine learning.Ann Med Surg (Lond). 2025 Jun 10;87(7):4145-4151. doi: 10.1097/MS9.0000000000003377. eCollection 2025 Jul. Ann Med Surg (Lond). 2025. PMID: 40851985 Free PMC article. Review.
-
Disparities in Peripheral Circulatory Complication-Related Mortality in Type 2 Diabetes Mellitus Patients: A CDC Analysis (1999-2020).Endocrinol Diabetes Metab. 2025 Sep;8(5):e70083. doi: 10.1002/edm2.70083. Endocrinol Diabetes Metab. 2025. PMID: 40731305 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Miscellaneous